CV Sciences, Inc.
CVSI
$0.03
$0.00-3.11%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.26M | 3.62M | 3.61M | 3.88M | 3.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.26M | 3.62M | 3.61M | 3.88M | 3.87M |
| Cost of Revenue | 1.68M | 1.78M | 1.95M | 2.21M | 2.09M |
| Gross Profit | 1.58M | 1.84M | 1.66M | 1.68M | 1.78M |
| SG&A Expenses | 1.83M | 1.93M | 2.14M | 2.06M | 2.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -522.00K | -- | -- |
| Total Operating Expenses | 3.53M | 3.75M | 3.60M | 4.29M | 4.33M |
| Operating Income | -275.00K | -131.00K | 11.00K | -403.00K | -461.00K |
| Income Before Tax | -382.00K | -261.00K | -102.00K | -740.00K | -456.00K |
| Income Tax Expenses | -- | -- | 7.00K | -14.00K | -- |
| Earnings from Continuing Operations | -382.00K | -261.00K | -109.00K | -726.00K | -456.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -382.00K | -261.00K | -109.00K | -726.00K | -456.00K |
| EBIT | -275.00K | -131.00K | 11.00K | -403.00K | -461.00K |
| EBITDA | -244.00K | -73.00K | 93.00K | -289.00K | -380.00K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 184.26M | 184.26M | 184.26M | 184.33M | 182.26M |
| Average Diluted Shares Outstanding | 184.26M | 184.26M | 184.26M | 184.33M | 182.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |